NASDAQ:BLRX - BIOLINERX LTD/S Stock Price, Forecast & News

BIOLINERX LTD/S trades on the NASDAQ under the ticker symbol "BLRX."

BIOLINERX LTD/S (NASDAQ:BLRX) issued its quarterly earnings data on Monday, November, 11th. The biotechnology company reported ($0.40) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.67) by $0.27. View BIOLINERX LTD/S's Earnings History.

BIOLINERX LTD/S is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for BIOLINERX LTD/S.

3 brokers have issued 12-month price targets for BIOLINERX LTD/S's shares. Their forecasts range from $3.00 to $10.00. On average, they anticipate BIOLINERX LTD/S's share price to reach $6.50 in the next year. This suggests a possible upside of 172.0% from the stock's current price. View Analyst Price Targets for BIOLINERX LTD/S.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIOLINERX LTD/S in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BIOLINERX LTD/S.

News headlines about BLRX stock have trended somewhat negative this week, InfoTrie reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. BIOLINERX LTD/S earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for BIOLINERX LTD/S.

BIOLINERX LTD/S saw a decline in short interest in November. As of November 29th, there was short interest totalling 110,800 shares, a decline of 23.3% from the November 14th total of 144,500 shares. Based on an average daily volume of 101,300 shares, the short-interest ratio is currently 1.1 days. Approximately 1.3% of the company's stock are short sold. View BIOLINERX LTD/S's Current Options Chain.

Some companies that are related to BIOLINERX LTD/S include Chembio Diagnostics (CEMI), Vaccinex (VCNX), Selecta Biosciences (SELB), Otonomy (OTIC), Elite Pharmaceuticals (ELTP), Neos Therapeutics (NEOS), Aclaris Therapeutics (ACRS), Clearside Biomedical (CLSD), Trevena (TRVN), Tiziana Life Sciences (TLSA), Entasis Therapeutics (ETTX), Alpine Immune Sciences (ALPN), ASLAN PHARMACEU/ADR (ASLN), Trevi Therapeutics (TRVI) and Infinity Pharmaceuticals (INFI).

Based on aggregate information from My MarketBeat watchlists, some companies that other BIOLINERX LTD/S investors own include Savara (SVRA), Synergy Pharmaceuticals (SGYP), Brainstorm Cell Therapeutics (BCLI), Ballard Power Systems (BLDP), Protalix Biotherapeutics (PLX), Advaxis (ADXS), Verastem (VSTM), Corbus Pharmaceuticals (CRBP), Actinium Pharmaceuticals (ATNM) and Eyepoint Pharmaceuticals (EYPT).

BIOLINERX LTD/S's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Orbimed Advisors LLC (0.93%) and Phoenix Holdings Ltd. (0.34%).

BLRX stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC.

BLRX stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd..

Shares of BLRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BLRX stock can currently be purchased for approximately $2.39.

BIOLINERX LTD/S has a market capitalization of $17.88 million. The biotechnology company earns $-22,960,000.00 in net income (profit) each year or ($3.15) on an earnings per share basis. BIOLINERX LTD/S employs 51 workers across the globe.View Additional Information About BIOLINERX LTD/S.

The official website for BIOLINERX LTD/S is http://www.biolinerx.com/.

BIOLINERX LTD/S's mailing address is 2 HAMA-AYAN STREET, MODI-IN L3, 7177871. The biotechnology company can be reached via phone at 972-2548-9100 or via email at [email protected]